Chronic Obstructive Pulmonary Disease

William Blake, an English poet, painter, and printmaker, way back in 1803, said: "What is now proved was once only imagined.". The quote stays fit in today's highly innovative and technologically sophisticated society. Innovation has brought many life-saving products and services that have significantly improved th...

A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has managed to net USD 2 million more by offering 40% more shares.  The company plans to use the funds raised to address the unmet needs in the Alzheimer’s disease market...

World COPD day observed on every 3rd Wednesday of November. This year, on 20th November, we are creating awareness about Chronic Obstructive Pulmonary Disease. COPD is one of the leading causes of mortality and morbidity worldwide. COPD is of two types: Emphysema and Chronic Bronchitis. According to a repor...

Levels of air pollution have risen dramatically over the past years due to increasing outdoor human activities such as industrialization, urbanization and indoor activities like burning of solid fuels, coal, etc. This has contaminated the air we breathe with several harmful substances such as Sulfur dioxide (SO2), ...

[caption id="attachment_3632" align="aligncenter" width="1387"]                                                                                                     COPD[/caption] Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lung...

Chronic obstructive pulmonary disease (COPD) is a progressive life-threatening lung disease which leads to airflow limitation and interferes with normal breathing. According to World Health Organization, approximately 64 million people are affected by COPD worldwide. World Health Organization estimates Chronic Obstr...

AstraZeneca has got good results in the clinical trial for its next-generation asthma medication and could be available to patients by the end of next year. The drug, Benralizumab, is a new biological treatment for people with severe asthma, and works by targeting eosinophils that cause inflammation in the lungs of ...